MEDICINOVA, INC. Liabilities Assumed
MEDICINOVA, INC. (MNOV) reported Liabilities Assumed of -$1.01 million for the 135-month period ending 2011-12-31, per its 10-K filed 2012-03-29.
Discontinued › Cash Flow › Other Cash Flow Items
us-gaap:LiabilitiesAssumed1 · last filed 2012-03-29
- MEDICINOVA, INC. liabilities assumed for fiscal 2009 was -$1.01M.
| Period end | Liabilities Assumed 12 month | Liabilities Assumed 135 month |
|---|---|---|
| 2011-12-31 | -$1.01M 10-K · filed 2012-03-29 | |
| 2009-12-31 | -$1.01M 10-K · filed 2012-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| CUMBERLAND PHARMACEUTICALS INC (CPIX) | United States | $0.121B | -8.95 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B |